Arrowpoint Investment Partners »

Silence Therapeutics shares owned by Arrowpoint Investment Partners

Quarter-by-quarter ownership of Silence Therapeutics (SLN) shares owned by Arrowpoint Investment Partners from 13F filings

Historical chart of Arrowpoint Investment Partners investment in Silence Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Silence Therapeutics held by Arrowpoint Investment Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Silence Therapeutics by Arrowpoint Investment Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $179k 16k 10.98

More positions owned by Arrowpoint Investment Partners

Vaneck Etf Trust Semiconductr Etf Call Option (SMH)
Citigroup Com New (C)
Goldman Sachs (GS)
State Str Spdr S&p 500 Etf T Tr Unit Call Option (SPY)
Global Payments (GPN)
Norfolk Southern (NSC)
American Electric Power Company (AEP)
NVIDIA Corporation (NVDA)
Exxon Mobil Corporation (XOM)
Ishares Msci Sth Kor Etf Put Option (EWY)
Ishares Msci Taiwan Etf (EWT)
Alphabet Cap Stk Cl A (GOOGL)
Micron Technology (MU)
Ishares Tr Expanded Tech Call Option (IGV)
Intel Corporation (INTC)

View all positions for Arrowpoint Investment Partners

Top funds holding Silence Therapeutics

Siren
TCG Crossover Management
Redmile Group
Nantahala Capital Management
Citadel Advisors
Polygon Management
Nextech Invest
Millennium Management
Ikarian Capital
Soleus Capital Management
Balyasny Asset Management
5AM Venture Management
Caption Management
Dr. Jeffrey R. Jay, M.D.
Jane Street

View all funds holding Silence Therapeutics